Pharmaceuticals News and Research

RSS

New way to assess pandemic potential of influenza viruses

Study provides first assessment of the risk of an H5N1 pandemic strain emerging from the combining of avian and human influenza viruses.

1 Aug 2006

FDA does an about turn on Plan B contraceptive pills

After years of dilly dallying over it's stand on over-the-counter sales of the "morning-after" contraceptive officials at the U.S. Food and Drug Administration (FDA) suddenly appear to be doing an about turn.

31 Jul 2006

US patent granted for 4SC's clinical Project

The Munich-based drug discovery and development company 4SC AG has been informed by the US Patent and Trademark Office (PTO) that the office has granted the patent with the US patent number 7,071,355.

27 Jul 2006

Promising therapy for Lou Gehrig's disease delivers antisense drug directly to nervous system

Researchers have designed and tested a molecular therapy in animals that they hope will be a major development in the fight to treat amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

27 Jul 2006

New bird flu vaccine has 80% protection rate

According to the manufacturer the latest bird flu vaccine is more than 80% effective in protecting people against the virus.

26 Jul 2006

Mylan granted U.S. patent for transdermal product

Mylan Laboratories has announced that U.S. Patent No. 7,070,808 was issued to its subsidiary, Mylan Technologies Inc. (MTI), on July 4, 2006.

26 Jul 2006

High rates of off-label prescriptions for antidepressant, anticonvulsant and antipsychotic drugs

A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.

26 Jul 2006

Birch bark compound may be potent prostate cancer fighter

A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.

25 Jul 2006

Nexavar approved in Europe for treatment of advanced kidney cancer

Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc have announced that the European Commission has granted marketing authorization to Nexavar (sorafenib) tablets for the treatment of patients with advanced renal cell carcinoma.

24 Jul 2006

Most women at high risk for breast cancer do not increase their life expectancy by taking the drug tamoxifen

Tamoxifen is an extraordinarily expensive cancer-prevention strategy, costing as much as $1.3 million per year of life saved.

24 Jul 2006

Digital magnetofluidics holds hope for better medicine

Critical advances in medicine and environmental protection promise to emerge from a new method for biochemical analysis of fluids developed by an international science team led in part by Arizona State University researchers.

21 Jul 2006

Patent issued for method to manufacture Immtech's drug candidate compounds

Immtech Pharmaceuticals has announced that The United States Patent and Trademark Office issued a patent related to the manufacturing of Immtech's drug candidate compounds.

21 Jul 2006

Industrial Biotechnology expands agreement with Oxford University

Industrial Biotechnology Corporation has announced the expansion of their License Agreement with Isis Innovation Limited, the technology transfer company of Oxford University.

21 Jul 2006

FDA warns against use of "bismacine," also known as chromocine

The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromocine.

21 Jul 2006

Ranbaxy to acquire the Mundogen generic business from GlaxoSmithKline

Ranbaxy, India's largest pharmaceutical company, and among the top ten generic pharmaceutical companies in the world, announced today that the Company has acquired the Mundogen generic business of GlaxoSmithKline.

19 Jul 2006

New hope for women with Alzheimer's disease

Leuprolide acetate helps women with mild-to-moderate Alzheimer's disease maintain functional capabilities for a longer period of time, according to data presented Monday by Voyager Pharmaceutical Corporation.

18 Jul 2006

Pioglitazone shows promise in treating Alzheimer's

Treatment of high blood sugar may have a scientific connection to memory loss that could, one day, benefit millions of people with Alzheimer's Disease, which affects up to 4.5 million older Americans, bringing with it impaired thinking and memory.

17 Jul 2006

Diblock copolymer micellar nanoparticles decorated with annexin-A5 proteins

One of the banes of modern cancer therapy is that clinicians and patients must often wait months before they can tell if a given treatment is working.

17 Jul 2006

Memory Pharmaceuticals achieves milestone for the treatment of neurological and psychiatric disorders

Memory Pharmaceuticals is to receive approximately $2.3M in funding from Roche in 2007.

17 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006